Acute Myeloid Leukaemia (AML) is one of the deadliest blood cancers, with a 5-year survival rate of less than 25%. There has been no dramatic improvement in AML treatments since the 1970s, but this group of researchers has identified a druggable Achille’s Heel, specific to AML and other blood cancers.
Novel treatment for leukaemia
Novel targeted treatment for Acute Myeloid Leukaemia
If you click the button and fill out the form to be “matched” with a technology, you will receive more detailed information about it and we will introduce you to the scientist / transfer manager of the respective research institution. In this way, you immediately have the chance to start discussions about a possible joint project in advance of all other participants who will not be given this opportunity until the Matching Day in January 2021.
In order to start the matching you need a ticket. If you already have one, please indicate your Eventbrite order number in the form. If not, just klick the button below.